Followers | 187 |
Posts | 14734 |
Boards Moderated | 0 |
Alias Born | 08/26/2010 |
Monday, December 04, 2023 10:11:10 PM
Recent VNDA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2024 10:45:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/14/2024 09:10:37 PM
- Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences • PR Newswire (US) • 11/12/2024 09:58:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 12:07:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:16:52 PM
- Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results • PR Newswire (US) • 11/06/2024 09:02:00 PM
- Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024 • PR Newswire (US) • 10/30/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 12:00:01 PM
- Ericsson Shares Surge 7% on Strong Earnings, Nvidia Drops 2%, Google Invests in Nuclear Power for AI • IH Market News • 10/15/2024 09:46:33 AM
- Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd. • PR Newswire (US) • 10/14/2024 02:56:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 09:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 12:10:32 PM
- FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis • PR Newswire (US) • 09/19/2024 11:00:00 AM
- Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference • PR Newswire (US) • 09/11/2024 09:00:00 PM
- Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference • PR Newswire (US) • 09/04/2024 09:13:00 PM
- Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference • PR Newswire (US) • 08/29/2024 08:30:00 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 08/08/2024 11:47:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:29:01 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 11:01:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:05:32 PM
- Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 07/31/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 09:24:41 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/29/2024 09:21:33 PM
- Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024 • PR Newswire (US) • 07/26/2024 01:19:00 PM
- Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex • PR Newswire (US) • 07/01/2024 12:01:00 PM
ILUS Announces Completion of QIND Acquisition by Fusion Fuel (NASDAQ: HTOO) • ILUS • Nov 27, 2024 12:35 PM
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer • BLO • Nov 26, 2024 8:48 AM
BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL • BQST • Nov 26, 2024 8:00 AM
BNCM Announces its Q3 and 9-Month Growth Results for 2024 • BNCM • Nov 26, 2024 7:03 AM
FoodTech Trailblazer Beyond Oil Appoints New COO from KFC Amidst Massive Global Expansion (OTCQB: BEOLF) (CSE: BOIL), up 250% this year • BOIL • Nov 25, 2024 11:12 AM
UC Asset announces plan of acquisition to increase awareness for its stock trading • UCASU • Nov 25, 2024 9:30 AM